Approval · Notice of Compliance 3455 · 2003
PROPOFOL INJECTION: Notice of Compliance 3455
Issued September 25, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3455
- Date
- September 25, 2003
- Company
- Mayne Pharma (Canada) Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anaesthetic-sedative
- Canadian reference product
- DIPRIVAN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFOL INJECTION | 02242973 | Cancelled Post Market |
Medicinal ingredients
- PROPOFOL 10 MG per ML